Dr. Winston is a pediatrician, engineer, and public health researcher conducting research at the interface of child and adolescent health, injury, engineering, and behavioral science. Her work focuses on traffic injury, and her research to action to impact approach has led to evidence-based digital health to improve health outcomes.
As a bioengineer, Dr. Arbogast's research focuses on pediatric injury biomechanics, injury causation and the effectiveness of safety products for children with a concentration in the safety of children and youth in motor vehicle crashes as well as pediatric concussion.
Dr. Tremoulet's current research interests include designing intelligent information systems that use human data (e.g. medical images, vital signs, reaction times, verbal, numerical or abstract reasoning assessments, neurological measures, etc.) to support healthcare and/or to improve job performance by enabling more effective human-machine interaction.
Dr. Waasdorp translates child development theory and literature into prevention and intervention programming, trials, research methodology, and related statistics. Her goals are to reduce bullying and aggression, improve children’s social and emotional skills, and help adults promote children’s positive peer relationships.
Dr. Graci aims to identify the mechanisms underlying injury to inform strategies and interventions to reduce injury and improve safety. She leverages her eclectic scientific background, spanning from experimental psychology to exercise science and biomechanics. Her research focuses on biomechanical risk factors for age-related falls, and injury mechanisms due to motor vehicle accidents.
Dr. Leff's background is in child clinical psychology, and he has broad training and expertise in intervention research, mixed methods, and in leading a range of federally funded research initiatives. His research goal is to use community-based participatory research (CBPR) to develop and validate school-based aggression and bullying intervention programs and assessment tools for urban minority youth.
Using translational approaches that encompass genomic studies, biomarker development, disease modeling, natural history studies, and clinical trials, Dr. Vanderver seeks to improve the quality of life and lifespan of individuals living with leukodystrophies or heritable disorder of myelin. She leads the Leukodystrophy Center of Excellence at Children's Hospital of Philadelphia.
Dr. Grimberg investigates the growth hormone (GH)/insulin-like growth factor (IGF)-I axis and clinical issues related to child growth. Her recent research is focused on disparities in, and the decision-making related to, the medical management of children with short stature. She is fascinated by how differential societal pressures for tallness and the advent of an expensive therapeutic have transformed a fundamental aspect of pediatric healthcare.